Impact of HIV infection and Kaposi Sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Johnston, Christine ^a,b   Orem, Jackson ^c   Okuku, Fred ^c   Kalinaki, Mary ^c   Saracino, Misty ^a   Katongole Mbidde, Edward ^c,d   Sande, Merle ^a,c,e   Ronald, Allan ^c,e   McAdam, Keith ^c   Huang, Meei Li ^a   Drolette, Linda ^a   Selke, Stacy ^a   Wald, Anna ^a,b   Corey, Lawrence ^a,b   Casper, Corey ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^e Academic Alliance for AIDS Care and Prevention in Africa   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENDEMIC DISEASE; EPIDEMIC; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; ORAL BIOPSY; OROPHARYNX; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; UGANDA; VIREMIA; VIRUS DETECTION; VIRUS REPLICATION; ADOLESCENT; METABOLISM; METHODOLOGY; MIDDLE AGED; MUCOSA; MULTIVARIATE ANALYSIS; VIROLOGY;

HUMAN HERPESVIRUS 8;

ADOLESCENT; ADULT; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; UGANDA; VIROLOGY; VIRUS REPLICATION;

EID: 58749111475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004222     Document Type: Article

References (39)

1. Lothe F (1963) Kaposi's Sarcoma in Uganda Africans. Acta pathol Microbiol Scand Suppl 161: 1.
2. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 82: 1585-1592.
3. Beral V (1991) The epidemiology of cancer in AIDS patients. AIDS 5: S99-103.
4. Gondos A, Brenner H, Wabinga H, Parkin DM (2005) Cancer survival in Kampala, Uganda. Br J Cancer 92: 1808-1812.
5. Huang YQ, Li JJ (1995) Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345: 759.
6. Moore PS, Chang Y (1998) Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 147:247-221.
7. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, et al. (1998) Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77: 817-820.
8. Wawer MJM, Eng SMM, Serwadda DM, Sewankambo NKMS, Kiwanuka NMp, et al. (2001) Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda. Sex Transm Dis 28: 77-81.
9. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, et al. (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2: 925-928.
10. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, et al. (1996) Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348: 1133-1138.
11. Pauk J, Huang NIL, Brodie SJ, Wald A, Koelle DM, et al. (2000) Mucosal Shedding of Human Herpesvirus 8 in Men. N Engl J Med 343: 1369-1377.
12. Casper C, Krantz E, Selke S, Kuntz SR, Wang J, et al. (2007) Frequent and Asymptomatic Oropharyngeal Shedding of Haman Herpesvirus 8 among Immunocompetent Men. J Infect Dis 195: 30-36.
13. Taylor MM, Chohan B, Lavreys L, Hassan W, Huang ML, et al. (2004) Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 190: 484-488.
14. Vieira J, Huang ML, Koelle DM, Corey L (1997) Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 71: 7083-7087.
15. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, et al. (1995) Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346: 799-802.
16. Campbell TB, Borok M, White IE, Gudza I, Ndemera B, et al. (2003) Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clin Infect Dis 36: 1144-1151.
17. Nsubuga MM, Biggar RJ, Combs S, Marshall V, Mbisa G, et al. (2008) Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Letters 263: 182-188.
18. Guttman-Yassky E, Abada R, Kra-Oz Z, Sattinger J, Perelman A, et al. (2007) Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patients. Diagnostic Microbiology and Infectious Disease 57: 387-392.
19. Krown SE, Metroka C, Wernz JC (1989) Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7: 1201-1207.
20. Wald A, Zeh J, Selke S, Ashley RL, Corey L (1995) Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections. N Engl J Med 333: 770-775.
21. Wald A, Zeh J, Selke S, Warren T, Ashley R, et al. (2002) Genital shedding of herpes simplex virus among men. J Infect Dis 186 Suppl 1: S34-39.
22. Wald A, Zeh J, Selke S, Warren T, Ryncarz A, et al. (2000) Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342: 844-850.
23. Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, et al. (2004) HIV Infection and Human Herpesvirus-8 Oral Shedding Among Men Who Have Sex with Men. J Acquir Immune Defic Syndr 35: 233-238.
24. Baeten JM, Chohan BH, Lavreys L, Rakwar JP, Ashley R, et al. (2002) Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya. Aids 16: 2073-2078.
25. Mbulaiteye S, Marshall V, Bagni RK, Wang CD, Mbisa G, et al. (2006) Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 193: 1250-1257.
26. Plancoulaine S, Abel L, van Beveren M, Tregouet D-A, Joubert M, et al. (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. The Lancet 356: 1062-1065.
27. Casper C, Wald A, Pauk J, Tabet SR, Corey L, et al. (2002) Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185: 990-993.
28. Lampinen, TM, Kulasingam S, Min J, Borok M, Gwanzura L, et al. (2000) Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women. J Infect Dis 181: 1785-1790.
29. Grundhoff A, Ganem D (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113: 124-136.
30. Guttman-Yassky E, Cohen A, Kra-Oz Z, Friedman-Birnbaum R, Sprecher E, et al. (2004) Familial clustering of classic Kaposi sarcoma. J Infect Dis 189: 2023-2026.
31. Cottoni E, Masia IM, Masala MV, Mulargia M, Contu L (1996) Familial Kaposi's sarcoma: case reports and review of the literature. Acta Derm Venereol 76: 59-61.
32. Plancoulaine SGA, van Beveren M, Tortevoye P, Abel L (2003) Evidence for a Recessive Major Gene Predisposing to Human Herpesvirus 8 (HHV-8) Infection in a Population in Which HHV-8 Is Endemic. J Infect Dis 187: 1944-1950.
33. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, et al. (2000) An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 96: 2562-2567.
34. Gandhi M, Koelle DM, Ameli N, Bacchedi P, Greenspan JS, et al. (2004) Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res 83: 639-643.
35. Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, et al. (2007) Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. Aids 21: 1541-1545.
36. Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, et al. (2008) Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 198: 23-30.
37. Ryncarz AJ, Goddard J, Wald A, Huang ML, Roizman B, et al. (1999) Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 37: 1941-1947.
38. Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, et al. (1998) Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAS. Virology 243: 208-217.
39. Magaret AS, Wald A, Huang M-L, Selke S, Corey L (2007) Optimizing PCR Positivity Criterion for Detection of Herpes Simplex Virus DNA on Skin and Mucosa. J Clin Microbiol 45: 1618-1620.